Genmab — December 2016
-
-
-
-
Medierne er oppe på dupperne denne gang.
-
FDA udsætter beslutning om Roches sklerosehåb
Schweiziske Roche må kigge længere efter en amerikansk godkendelse af et yderst lovende lægemiddel mod sklerose, der har potentiale til at kunne bruges til op mod 95 pct. af de folk, der diagnosticeres med sygdommen.
(medwatch.dk)
-
Tror desværre OHW har ret

-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
